Trends in use of poly (ADP-ribose) polymerase inhibitor (PARPi) in ovarian cancer

Cancer Epidemiology 2026

View at publisher
Authors: Joseph A. Dottino, Katherine Baumann, Katharine M. Esselen, Rebecca L Costa, Stephanie Argetsinger, Dennis Ross‐Degnan, Anita K. Wagner
DOI: 10.1016/j.canep.2026.102996
Cited by: 1
References: 23

Fields of Study & Subjects

PARP inhibition in cancer therapy Ovarian cancer diagnosis and treatment Lung Cancer Research Studies

Publication details

Journal / source
Cancer Epidemiology
Publisher
Elsevier BV
Volume
101
Pages
102996–102996
Publication date
22 January 2026
Language
EN